# US 2025/0085226 A1 · Specimen analyzer and specimen analysis method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0085226 A1
- Document ID: US20250085226A1
- Status: Published application
- Kind: A1
- Application number: 18/829,666
- Filed: 2024-09-10
- Published: 2025-03-13
- Earliest claimed: 2023-09-13
- Assignees: Sysmex Corporation; University of Toyama
- Applicants: Sysmex Corporation; University of Toyama
- Inventors: Rinako YOSHIDA; Yosuke IWASAKI; Hideki NIIMI; Yoshihiro YAMAMOTO; Yuki MIYAJIMA; Makito KANEDA
- Web page: https://patentgrep.com/patent/US20250085226A1

## CPC

- G01N 15/1459: {the analysis being performed on a sample stream}
- G01N 21/6486: {Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence)}
- G01N 15/1429: Signal processing
- G01N 21/05: Flow-through cuvettes (G01N21/09 takes precedence; handling fluid samples G01N1/10)
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/582: {with fluorescent label}
- G01N 2015/016: {White blood cells}
- G01N 2015/1006: {for cytology}
- G01N 2015/1402: {Data analysis by thresholding or gating operations performed on the acquired signals or stored data}
- G01N 2015/1477: {Multiparameters}
- G01N 2015/1486: {Counting the particles}
- G01N 2021/052: {Tubular type; cavity type; multireflective}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A specimen analyzer including: a measurement part configured to apply light to a measurement sample and a fluorescent dye that stains white blood cells contained in the blood specimen, detect fluorescence from the white blood cells contained in the measurement sample to which the light has been applied, and measure fluorescence signals on the basis of the detected fluorescence; an information processing part configured to generate, on the basis of the fluorescence signals, information about a distribution width of fluorescence intensities regarding a population of neutrophils contained in the measurement sample, and determine information about a degree of severity of an organ dysfunction due to an infection on the basis of the information about the distribution width of the fluorescence intensities regarding the population of neutrophils; and an output part configured to output the information about the degree of severity of the organ dysfunction due to the infection.

## Claims

### Claim 1

A specimen analyzer comprising:
a measurement part configured to
apply light to a measurement sample containing a blood specimen and a fluorescent dye that stains white blood cells contained in the blood specimen,
detect fluorescence from the white blood cells contained in the measurement sample to which the light has been applied, and
measure fluorescence signals on the basis of the detected fluorescence;
an information processing part configured to
generate, on the basis of the fluorescence signals, information about a distribution width of fluorescence intensities regarding a population of neutrophils contained in the measurement sample, and
determine information about a degree of severity of an organ dysfunction due to an infection on the basis of the information about the distribution width of the fluorescence intensities regarding the population of neutrophils; and
an output part configured to output the information about the degree of severity of the organ dysfunction due to the infection.

### Claim 2 (depends on 1)

The specimen analyzer of claim 1, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes flag information indicates
that a subject from whom the blood specimen has been collected is suspected of suffering from sepsis, or
a level of a possibility that the subject suffers from sepsis.

### Claim 3 (depends on 1)

The specimen analyzer of claim 1, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes an estimated score indicating the degree of severity of the organ dysfunction due to the infection.

### Claim 4 (depends on 1)

The specimen analyzer of claim 1, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes a range of an estimated score indicating the degree of severity of the organ dysfunction due to the infection.

### Claim 5 (depends on 3)

The specimen analyzer of claim 3, wherein
the information about the distribution width of the fluorescence intensities regarding the population of neutrophils indicates the distribution width of the fluorescence intensities regarding the population of neutrophils, and,
as the distribution width becomes larger, the estimated score indicating the degree of severity of the organ dysfunction due to the infection becomes larger.

### Claim 6 (depends on 5)

The specimen analyzer of claim 5, wherein
the estimated score indicating the degree of severity of the organ dysfunction due to the infection is an estimated value of a SOFA score.

### Claim 7 (depends on 6)

The specimen analyzer of claim 6, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes information indicating whether or not an estimated value of a difference between the SOFA score in an initial stage of hospitalization and the SOFA score in a healthy state is equal to or larger than a threshold value.

### Claim 8 (depends on 1)

The specimen analyzer of claim 1, wherein
the measurement part includes a preparation part configured to prepare the measurement sample.

### Claim 9 (depends on 1)

The specimen analyzer of claim 1, wherein
the measurement part includes a flow cell configured to allow the measurement sample to flow therethrough and applies the light to the measurement sample flowing through the flow cell.

### Claim 10 (depends on 1)

The specimen analyzer of claim 1, comprising at least one of the following configurations [11] to [18]:
[11] a configuration in which the information about the degree of severity of the organ dysfunction due to the infection includes flag information indicating that a subject from whom the blood specimen has been collected is suspected of suffering from sepsis;
[12] a configuration in which the information about the degree of severity of the organ dysfunction due to the infection includes an estimated score indicating the degree of severity of the organ dysfunction due to the infection;
[13] a configuration in which the information about the degree of severity of the organ dysfunction due to the infection includes a range of an estimated score indicating the degree of severity of the organ dysfunction due to the infection;
[14] a configuration in which the information about the distribution width of the fluorescence intensities regarding the population of neutrophils indicates the distribution width of the fluorescence intensities regarding the population of neutrophils, and, as the distribution width becomes larger, the estimated score indicating the degree of severity of the organ dysfunction due to the infection becomes larger;
[15] a configuration in which the estimated score indicating the degree of severity of the organ dysfunction due to the infection is an estimated value of a SOFA score;
[16] a configuration in which the flag information includes information indicating whether or not an estimated value of a difference between a SOFA score in an initial stage of hospitalization and a SOFA score in a healthy state is equal to or larger than a threshold value;
[17] a configuration in which the measurement part includes a preparation part configured to prepare the measurement sample; and
[18] a configuration in which the measurement part includes a flow cell configured to allow the measurement sample to flow therethrough and applies the light to the measurement sample flowing through the flow cell.

### Claim 11

A specimen analysis method comprising:
applying light to a measurement sample containing a blood specimen and a fluorescent dye that stains white blood cells contained in the blood specimen, detecting fluorescence from the white blood cells contained in the measurement sample to which the light has been applied, and measuring fluorescence signals on the basis of the detected fluorescence;
generating, on the basis of the fluorescence signals, information about a distribution width of fluorescence intensities regarding a population of neutrophils contained in the measurement sample;
determining information about a degree of severity of an organ dysfunction due to an infection on the basis of the information about the distribution width of the fluorescence intensities regarding the population of neutrophils; and
outputting the information about the degree of severity of the organ dysfunction due to the infection.

### Claim 12 (depends on 11)

The specimen analysis method of claim 11, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes flag information indicates
that a subject from whom the blood specimen has been collected is suspected of suffering from sepsis, or
a level of a possibility that the subject suffers from sepsis.

### Claim 13 (depends on 11)

The specimen analysis method of claim 11, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes an estimated score indicating the degree of severity of the organ dysfunction due to the infection.

### Claim 14 (depends on 11)

The specimen analysis method of claim 11, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes a range of an estimated score indicating the degree of severity of the organ dysfunction due to the infection.

### Claim 15 (depends on 13)

The specimen analysis method of claim 13, wherein
the information about the distribution width of the fluorescence intensities regarding the population of neutrophils indicates the distribution width of the fluorescence intensities regarding the population of neutrophils, and,
as the distribution width becomes larger, the estimated score indicating the degree of severity of the organ dysfunction due to the infection becomes larger.

### Claim 16 (depends on 13)

The specimen analysis method of claim 13, wherein
the estimated score indicating the degree of severity of the organ dysfunction due to the infection is an estimated value of a SOFA score.

### Claim 17 (depends on 16)

The specimen analysis method of claim 16, wherein
the information about the degree of severity of the organ dysfunction due to the infection includes information indicating whether or not an estimated value of a difference between the SOFA score in an initial stage of hospitalization and the SOFA score in a healthy state is equal to or larger than a threshold value.

### Claim 18 (depends on 11)

The specimen analysis method of claim 11, wherein
the measuring further includes preparing the measurement sample.

### Claim 19 (depends on 11)

The specimen analysis method of claim 11, wherein
the measuring further includes causing the measurement sample to flow through a flow cell, and
the applying included in the measuring includes applying the light to the measurement sample flowing through the flow cell.
